Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance

Purpose To evaluate pancreatic T1 mapping and extracellular volume (ECV) fraction’s feasibility to assess impaired glucose tolerance (IGT) patients. Methods A total of 45 consecutive patients with known or suspected pancreatic disease underwent contrast-enhanced magnetic resonance (MR) imaging, incl...

Full description

Saved in:
Bibliographic Details
Published in:Abdominal imaging 2020-02, Vol.45 (2), p.449-456
Main Authors: Noda, Yoshifumi, Goshima, Satoshi, Tsuji, Yusuke, Kajita, Kimihiro, Akamine, Yuta, Kawai, Nobuyuki, Kawada, Hiroshi, Tanahashi, Yukichi, Matsuo, Masayuki
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biomarkers
Biomarkers - blood
Contrast Media
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Female
Fibrosis
Gastroenterology
Glucose
Glucose Intolerance
Glucose tolerance
Hepatology
Humans
Imaging
Informed consent
Intolerance
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Mapping
Medical imaging
Medicine
Medicine & Public Health
Middle Aged
Organ Size
Pancreas
Pancreatic diseases
Pancreatic Diseases - diagnostic imaging
Radiology
Sensitivity and Specificity
Signal-To-Noise Ratio
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To evaluate pancreatic T1 mapping and extracellular volume (ECV) fraction’s feasibility to assess impaired glucose tolerance (IGT) patients. Methods A total of 45 consecutive patients with known or suspected pancreatic disease underwent contrast-enhanced magnetic resonance (MR) imaging, including T1 mapping, using saturation recovery sequence. Patients were classified into three groups based on the American Diabetes Association criteria: no-diabetes subjects, HbA1c 
ISSN:2366-004X
2366-0058
DOI:10.1007/s00261-019-02384-7